Chow PM, Kuo HC. Botulinum toxin A injection for autonomic dysreflexia-detrusor injection or urethral sphincter injection? Toxins (Basel). 2023;15:108.

Article  CAS  PubMed  Google Scholar 

Devivo MJ. Epidemiology of traumatic spinal cord injury: trends and future implications. Spinal Cord. 2012;50:365–72.

Article  CAS  PubMed  Google Scholar 

Wöllner J, Pannek J. Initial experience with the treatment of neurogenic detrusor overactivity with a new β-3 agonist (mirabegron) in patients with spinal cord injury. Spinal Cord. 2016;54:78–82.

Article  PubMed  Google Scholar 

Huang YH, Chen SL. Concomitant detrusor and external urethral sphincter botulinum toxin-A injections in male spinal cord injury patients with detrusor overactivity and detrusor sphincter dyssynergia. J Rehabil Med. 2022;54:jrm00264.

Article  PubMed  Google Scholar 

Mehta S, Hill D, McIntyre A, Foley N, Hsieh J, Ethans K, et al. Meta-analysis of botulinum toxin A detrusor injections in the treatment of neurogenic detrusor overactivity after spinal cord injury. Arch Phys Med Rehabil. 2013;94:1473–81.

Article  PubMed  Google Scholar 

Bellucci CH, Wöllner J, Gregorini F, Birnböck D, Kozomara M, Mehnert U, et al. Acute spinal cord injury-do ambulatory patients need urodynamic investigations? J Urol. 2013;189:1369–73.

Article  PubMed  Google Scholar 

Chen SF, Jiang YH, Kuo HC. Single onabotulinumtoxinA 200U dose improved clinical symptoms but not urothelial dysfunction in neurogenic detrusor overactivity due to spinal cord injury. J Formos Med Assoc. 2019;118:125–33.

Article  PubMed  Google Scholar 

Giannantoni A, Mearini E, Del Zingaro M, Porena M. Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results. Eur Urol. 2009;55:705–11.

Article  CAS  PubMed  Google Scholar 

Julian PTH, James T, Jacqueline C, Miranda C, Tianjing L, Matthew JP, et al. Cochrane Handbook for Systematic Reviews of Interventions. John Wiley & Sons; 2019.

Google Scholar 

Matthew JP, Joanne EM, Patrick MB, Isabelle B, Tammy CH, Cynthia DM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.

Google Scholar 

Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. Bmj. 2011;343:d5928.

Article  PubMed  PubMed Central  Google Scholar 

R Core Team (2023). _R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria. https://www.R-project.org/.

Reitz A, Stöhrer M, Kramer G, Del Popolo G, Chartier-Kastler E, Pannek J, et al. European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity. Eur Urol. 2004;45:510–5.

Article  CAS  PubMed  Google Scholar 

Cochran GW. The comparison of percentages in matched samples. Biometrika. 1950;37:256–66.

Article  CAS  PubMed  Google Scholar 

Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.

Article  PubMed  Google Scholar 

Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.

Article  PubMed  PubMed Central  Google Scholar 

McGuinness L robvis: An R package and web application for visualising risk-of-bias assessments [Internet]. 2019.

Lin CC, Kuo HC. Video-urodynamic characteristics and predictors of switching from botulinum neurotoxin a injection to augmentation enterocystoplasty in spinal cord injury patients. Toxins (Basel). 2022;14:47.

Article  PubMed  Google Scholar 

Honda M, Yokoyama O, Takahashi R, Matsuda T, Nakayama T, Mogi T. Botulinum toxin injections for Japanese patients with urinary incontinence caused by neurogenic detrusor overactivity: Clinical evaluation of onabotulinumtoxinA in a randomized, placebo-controlled, double-blind trial with an open-label extension. Int J Urol. 2021;28:906–12.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen H, Xie K, Jiang C. A single-blind randomized control trial of trigonal versus nontrigonal Botulinum toxin-A injections for patients with urinary incontinence and poor bladder compliance secondary to spinal cord injury. J Spinal Cord Med. 2021;44:757–64.

Article  CAS  PubMed  Google Scholar 

Walter M, Kran SL, Ramirez AL, Rapoport D, Nigro MK, Stothers L, et al. Intradetrusor onabotulinumtoxinA injections ameliorate autonomic dysreflexia while improving lower urinary tract function and urinary incontinence-related quality of life in individuals with cervical and upper thoracic spinal cord injury. J Neurotrauma. 2020;37:2023–7.

Article  PubMed  PubMed Central  Google Scholar 

Hebert KP, Klarskov N, Bagi P, Biering-Sørensen F, Elmelund M. Long term continuation with repeated Botulinum toxin A injections in people with neurogenic detrusor overactivity after spinal cord injury. Spinal Cord. 2020;58:675–81.

Article  PubMed  Google Scholar 

Hui C. Safety and efficacy of trigonal BTX-A injections for children with neurological detrusor overactivity secondary to spinal cord injury. J Pediatr Surg. 2020;55:2736–9.

Article  PubMed  Google Scholar 

Walter M, Kran SL, Nigro MK, Stothers L, Rapaport D, Kavanagh A, et al. Onabotulinumtoxina ameliorates autonomic dysreflexia while improving lower urinary tract function and quality of life in individuals with spinal cord injury. Neurourol Urodyn. 2018;37:S88–S9.

Google Scholar 

Ferreira RS, D’Ancona CAL, Oelke M, Carneiro MR. Intradetrusor onabotulinumtoxinA injections are significantly more efficacious than oral oxybutynin for treatment of neurogenic detrusor overactivity: results of a randomized, controlled, 24-week trial. Einstein (Sao Paulo). 2018;16:eAO4207.

Article  PubMed  Google Scholar 

Huang Y-H, Chen S-L, editors. Concomitant onabotulinumtoxinA detrusor and sphincter injection in patients with suprasacral spinal cord injury. Int J Urol. 2018: Wiley 111 River ST, Hoboken 07030-5774, NJ USA.

Fougere RJ, Currie KD, Nigro MK, Stothers L, Rapoport D, Krassioukov AV. Reduction in bladder-related autonomic dysreflexia after onabotulinumtoxinA treatment in spinal cord injury. J Neurotrauma. 2016;33:1651–7.

Article  PubMed  PubMed Central  Google Scholar 

Chen SF, Chang CH, Kuo HC. Clinical efficacy and changes of urothelial dysfunction after repeated detrusor botulinum toxin A injections in chronic spinal cord-injured bladder. Toxins (Basel). 2016;8:164.

Article  PubMed  Google Scholar 

Hui C, Keji X, Chonghe J, Ping T, Rubiao O, Jianweng Z, et al. Combined detrusor-trigone BTX-A injections for urinary incontinence secondary to neurogenic detrusor overactivity. Spinal Cord. 2016;54:46–50.

Article  CAS  PubMed  Google Scholar 

Al Taweel W, Alzyoud KM. The effect of spinal cord-injury level on the outcome of neurogenic bladder treatment using OnabotulinumtoxinA. Urol Ann. 2015;7:320–4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang WX, Zhu HJ, Chen WG, Zhang DW, Su M, Feng JF, et al. Treatment of detrusor external sphincter dyssynergia using ultrasound-guided trocar catheter transurethral botulinum toxin a injection in men with spinal cord injury. Arch Phys Med Rehabil. 2015;96:614–9.

Article  PubMed  Google Scholar 

Sengoku A, Okamura K, Kimoto Y, Ogawa T, Namima T, Yamanishi T, et al. Botulinum toxin A injection for the treatment of neurogenic detrusor overactivity secondary to spinal cord injury: multi-institutional experience in Japan. Int J Urol. 2015;22:306–9.

Article  CAS  PubMed  Google Scholar 

Álvares RA, Araújo ID, Sanches MD. A pilot prospective study to evaluate whether the bladder morphology in cystography and/or urodynamic may help predict the response to botulinum toxin a injection in neurogenic bladder refractory to anticholinergics. BMC Urol. 2014;14:66.

Article  PubMed  PubMed Central  Google Scholar 

Fougere RJ OnabotulinumtoxinA treatment for neurogenic detrusor overactivity and the prevention of autonomic dysreflexia following spinal cord injury: University of British Columbia; 2014.

Chen YC, Kuo HC. The therapeutic effects of repeated detrusor injections between 200 or 300 units of onabotulinumtoxinA in chronic spinal cord injured patients. Neurourol Urodyn. 2014;33:129–34.

Article  CAS  PubMed  Google Scholar 

Chen SF, Kuo HC. Therapeutic outcome and patient adherence to repeated onabotulinumtoxinA detrusor injections in chronic spinal cord-injured patients and neurogenic detrusor overactivity. J Formos Med Assoc. 2015;114:583–9.

Article  CAS  PubMed  Google Scholar 

Jia C, Liao LM, Chen G, Sui Y. Detrusor botulinum toxin A injection significantly decreased urinary tract infection in patients with traumatic spinal cord injury. Spinal Cord. 2013;51:487–90.

Article  CAS  PubMed  Google Scholar 

Šámal V, Mečl J, Šrám J. Submucosal administration of onabotulinumtoxinA in the treatment of neurogenic detrusor overactivity: pilot single-centre experience and comparison with standard injection into the detrusor. Urol Int. 2013;91:423–8.

Article  PubMed  Google Scholar 

Apostolidis A, Thompson C, Yan X, Mourad S. An exploratory, placebo-controlled, dose-response study of the efficacy and safety of onabotulinumtoxinA in spinal cord injury patients with urinary incontinence due to neurogenic detrusor overactivity. World J Urol. 2013;31:1469–74.

Article  CAS  PubMed  Google Scholar 

Chen S-F, Kuo H-C. Improvement in autonomic dysreflexia after detrusor onabotulinumtoxinA injections in patients with chronic spinal cord injuries. Tzu Chi Med J. 2012;24:201–4.

Article  Google Scholar 

Krhut J, Samal V, Nemec D, Zvara P. Intradetrusor versus suburothelial onabotulinumtoxinA injections for neurogenic detrusor overactivity: a pilot study. Spinal Cord. 2012;50:904–7.

Article  CAS  PubMed  Google Scholar